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Introduction 
 Crescentic glomerulonephropathy is chatacterized clinically by rapid deteoration of 
renal function, and histlogically by mononuclear cell infiltration of the glomeruli, 
glomerular cell proliferation, crescent formation and eventually glomerulosclerosis.  A 
number of studies have attempted to control cellular pathways that contribute to 
autoimmune responses and the subsequent inflammatory cascade that leads to prigressive 
autoimmune disease(1).    The mechanisms controlling progression of 
glomerulonephritis are poorly understood.  An imbalance in the T helper 1 (Th1)/Th2 
ratio is thought to be indicative of pathogenesis.  In past studies crescentic nephritis is 
thought to be Th1 predomoinance(1,2). 
In Wistar-Kyoto (WKY) rats, a very small dose of nephrotoxic serum induces severe 
proliferative and necrotizing glomerulonephritis with crescentic formation, resembling 
human crescentic glomerulonephritis.  Renal damage eventually leads to 
glemerulonephritis and interstitial fibrosis(3).  WKY rats are prone to Th1 immune 
responses, and useful model to analyse the mechanism of crescentic glomerulonephritis. 
Antirheumatoid arthritis drug TAK–603, (ethyl 
4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)-quinoline-3-carbo
xylate), reduces Th1 cytokines, such as IFN-γ，IL-2，IL-12(4).  In past studies, this 
drug controls the progression of synovial injury and arthritis in adjuvant arthritis rats(5), 
therapeutic effect on graft versus host disease(4), and rat skin allograft survival(6).  
However, the mechanism how this drug affects is still unknown. 
Therefore we hypothesized that TAK-603 supresses Th1 dominant T cells, and 
ameliorates crescentic glomerulonephritis.  To achieve this goal, we evaluate crescentic 
glomerulonephritis induced by WKY rats and rats treated with TAK-603.  We report 
here that suppression of Th1 cytokines represents a beneficial therapeutic approach for 
crescentic glomerulonephritis. 
Material and methods 
Animals 
 Male WKY rats, ages 8 to 10 weeks were purchased from Charles River Japan Inc 
(Atsugi, Japan).  All procedures used in animal experiments complied with standards in 
the Guidelines for the Care and Use of Laboratory Animals in Takara-machi Campus of 
Kanazawa University. 
 
Preparation of Antirat Glomerular Basement Membrane Antibodies 
 Rat glomerular basement membrane (GBM) was prepared using the method of 
Krakower and Greenspon(7).  Preparation of antirat GBM antibodies was described 
previously(3).  Specificity was confirmed by in vitro indirect immunofluorescence using 
fluorescein isothiocyanate (FITC)-conjugated antirabbit immunoglobulin G (IgG; 




 Fourty-eight male WKY rats were injected intravenously with 0.1mL of nephrotoxic 
serum day 0.  WKY rats were divided into three groups, and experimental design was 
described in Figure 1.  TAK-603 (50mg/kg body weight), dissolved in methylcellulose, 
was orally administrated, starting at the time of induction of glomerulonephritis.  Twelve 
of 48 rats were administered daily for 6 days.  Nephritic rats were killed at day 6 (6 rats) 
or at day 56 (6 rats), and blood samples were collected.  Similarly twelve rats were 
administered at day 0 and killed at day 6 (6 rats) and day 56 (6rats), and twelve rats  were 
administered from day 3 to 5, and killed at day6 (6 rats) and day 56 (6 rats).  Twelve rats 




 A portion of renal tissue was fixed in 10% buffered formalin, followed by embedding in 
paraffin and staining with hematoxylin and eosin, as well as periodic acid-Schiff reagent.  
To avoid variation in the shape of glomeruli, glomeruli of the same diameter from a 
vascular pole were chosen.  Crescentic formation was counted from more than 30 
glomeruli for each rat and expressed as a percentage of positive to total glomeruli.  Cell 
populations infiltrating glomeruli were counted in 10 randomly chosen glomeruli, and the 
result was expressed as total cell numbers per glomerus.  
 
Immunohistology 
 To analyse cell populations infiltrating glomeruli, cryostat sections were stained with 
either a mouse monoclonal antibody against ED-1 (BMA Biomedicals 
Ltd.Augst,Switzerland) for monocyte and macrophages, CD4, and CD8 (BMA 
Biomedicals Ltd.Switzerland) for CD4+ lymphocytes, followed by FITC-conjugated 
rabbit antimouse IgG (Cappel, West Chester, PA, USA).  Positive cells were counted in 
at least 10 randomly chosen glomeruli and the result was expressed as number of positive 
cells per glomerular cross-section. 
 
Electron microscopy 
 Renal tissue was fixed in 2.5% glutalaldehyde and 4% osmic acid, followed by 
embedding in Epok812 (Oken , Tokyo) and staining with uranyl acetate.  This specimen 
was observed with electron microscopy (Hitachi, Tokyo, Japan). 
 
Determination of Urinary Protein Concentration, Creatinine, IFN-γand IL-4 
 Urinary protein concentrations were determined before immunization, days 0, 6 and 56 
at the time rats were killed.  Urinary protein excretion was expressed as the total amount 
excreted in a 24-hour period.  Urinary creatinine level was measured using an automated 
analyzer (Hitachi, Tokyo, Japan) according to the manufacture’s instructions.  Urinary 
IFN-γand IL-4 were measured by an enzyme-linked immunosorbent assay (R&D 
systems, Mineapolis, MN, USA).  Urinary Protein Concentration, IFN-γand IL-4 were 
collected by urinary creatinine. 
 
RNA isolation and RT-PCR 
 Total cellular RNA was isolated from the cortices, and analyses were performed using 
reverse transcriptase polymerase chain reaction (RT-PCR), as previously described(8).  
Reverse transcription for 6μg total RNA, from 6 rats in each group(1μg RNA per a rat), 
was performed using a RT-PCR kit(Perkin Elmer, Foster City, CA, USA).  The 
complementary DNA product(1μg) was amplied by PCR.  The primer of rat IL-12p35 
was purchased from Biosourse International(amplified fragment of 555bp)(9), and the 
other primers used for amplification are shown in Table 1.  Ten microliters of PCR 
products were analyzed using 2% agarose gel electrophoresis, and stained with ethidium 
bromide.  The housekeeping gene GAPDH was used for PCR controls. 
 
Statistical analyses 
 Mean and SE were calculated on all parameters determined in this study.  Statistical 
analyses were performed using Kruskal-Wallis test.  P less than 0.05 is accepted as 
statistically significant. 
Results 
TAK-603 reduced renal lesions in WKY rats. 
Immunofluorescence analysis revealed no deposition of rabbit IgG in glomeruli from 
normal WKY rats.  Rabbit IgG was detected in an intense linear pattern along the 
glomerular capillaries from nephrotoxic serum injected rats administered TAK-603 or 
vehicle (data not shown). 
Glomerular lesions exhibited endocapillary proliferation, severe necrotizing lesions and 
crescentic formation.  In contrast, administration of TAK-603 drastically reduced severe 
crescentic lesions and necrotizing lesions, which were observed both on day 6 and 56 in 
control animals (Figure 2).  TAK-603 prevented the development of crescents per 100 
glomeruli in section (Figure 3a).  The total number of glomerular cells was also reduced 
(Figure 3b). 
On day 56, interstitial fibrosis was clearly suppressed in Group 1 and 3.  Glomerular 
sclerosis revealed the tendency of improvement in Group 1(Figure 4). 
 
Reduced population of leukocyte populations in WKY rats. 
 Numbers of both CD-4- and ED-1-positive cells were dramatically reduced with the 
administration of TAK-603 in all of three groups, compared with untreated rats on day 6 
(Figure 3c and d). 
 
Effect of TAK-603 on urinary protein secretion and electron microscopic study. 
Normal rats excreted minute amounts of protein in the urine on day 6.  Proteinuria was 
dramatically decreased by the administration of TAK-603 in Group 1 and 3, but not in 
Group 2.  On day 56, proteinuria was decreased in all of three groups (Figure 5a).   
By electron microscopy, an extensive fusion of the foot processes around the infiltrated 
leukocytes was observed in untreated rats but not in Group 1, which reflects decreased 
proteinuria (Figure 5b and 5c). 
 
Effect of TAK-603 on serum creatinine. 
Serum creatinine concentrations at day 6 were not different whether TAK-603 was 
administered or not.  On day 56, compaired with untreated rats, serum creatinine 
concentrations were depressed in all TAK-603 treated groups (Figure 6). 
 
RT-PCR analysis of cytokine in mRNA levels. 
 In untreated rats,γ-IFN and IL-2 mRNA were elevated.  After administration of 
TAK-603, γ-IFN and IL-2 mRNA were significantly downregulated in Group 1, and 
appeared decreasing tendency in Group 2 and 3 (Figure 7).  
 
Effects of TAK-603 on Urinary γ-IFN and IL-4. 
Urinary γ -IFN level was normal in normal rats.  On day 6, it was elevated to 
0.7pg/mlCr in untreated rats. In contrast, it was  decresed to normal level by 
administration of TAK-603.  Urinary IL-4 levels were normal in any groups (data not 
shown). 
Discussion 
In this report, we established a hypothesis that suppression of Th1 cytokines ameliorates 
crescentic glomerulonephritis.  Therefore we investigate the therapeutic effect of 
TAK-603 on crescentic glomerulonephritis through the selective inhibitory effect to Th1 
T cells. 
Production of IgG2a and Th1 cytokines, such as IFN-γ, IL-2, IL-12 gives a notion that 
glomerulonephritis is prone to Th1 dominant（15,16）.  The role of IFN-γ is mostly 
investigated.  Kitching et al. suggested that in crescentic glomerulonephritis model with 
C57BL/6 mouse, which is thought to Th1 dominant, genetical deficiency in IFN-γ
demonstrates suppression of crescentic formation and improvement of glomerular 
injury(17).  Recently, IFN-γ produciting cell was found in Bone marrow transplanted 
IFN-γ-deficient chimeric mice(18).  These results suggests that IFN-γ expression by 
both bone marrow-derived cells and intrinsic renal cells is required for the development 
of crescentic glomerulonephritis.  For the present, there is no idea to control  Th1 cells 
or Th1 cytokines directly.  In past studies, trials that suppress crescentic 
glomerulonephritis by control Th1/Th2 balance were made.  Tipping and Kitching et al. 
reported administration of Th2cytokines IL-4 and IL-10 improved 
glomerulonephritis(19,20).  It is interesting that even after glomerulonephritis was 
induced, controlled Th1/Th2 balance  suppressed nephritis.  Indeed in our study, 
administration of TAK-603 from day 3 had an effect on suppress crescent formation. 
Number of  infiltrating CD-4- and ED-1-positive cells were clearly reduced by 
administration of TAK-603.  The role of T cells and macrophages to crescent formation 
in WKY rat is reported.  Wada et al. reported that administration of neutralizing antibody 
to monocyte chemoattractant protein-1(MCP-1)/CCL2, which acts on infiltration and 
activation of T cells and macrophages, improved crescent formation and other glomerular 
lesions, and reduced proteinuria(3).  In the other reports, , MCP-1 and Th1 chemokines, 
such as macrophage inflammatory protein-1 α (MIP-1 α )/CCL3 and regulated on 
activation normal T-cell expressed and secreted(RANTES)/CCL5 may participate in 
activation of human crescentis glomerulonephritis（21,22） .  The receptor of these 
chemokines ＣＣＲ5 specifically manifests on Th1 cells(23).  And, IFN-γ acts on 
mesangium cells and products MCP-1, MIP-1α and RANTES(24,25）.  These findings 
give speculation that in Th1 predominance, production of chemokine from glomerular 
intrinsic cell and Th1 T cells induce filtration and of T cell and macrophage into 
glemerulus and their activation.   
In our study administration of TAK-603 also reduce amount of proteinuria.  Electron 
microscopy findings showed that extensive fusion of the foot processes was suppressed 
around the infiltrated leukocytes.  From this result it seems that administration of ＴＡＫ
-603 suppressed not only filtration of T cells and macrophage but also activation of 
infiltrated cells.  In fact, the amount of proteinuria was mostly suppressed in Group1.  
In past reports, the possibility id shown that secretion of lysosome and production of 
superoxide from infiltrated cells induce destruction of basement membrane and directly 
obstruct epithelial cell and endothelial cells, and result in production of 
proteinuria(26,27).  In our study, it seems the possibility that administration of TAK-603 
suppressed activation of infiltration cells and epithelial cells injury, result in reduction of 
proteinuria. 
WKY rats are known to be more susceptible to anti GBM antibody than other strains, 
and develop progressive proteinuria and crescentic glomerulonephritis(3,8).  
Holdsworth et al. reported that medication of neutralizing antibody to IFN-γ  or 
recombinant IL-4 and IL-10 reduce crescentic glomerulonephritis(15).  These results 
suggest the possibility that administration of Th1/Th2 cytokines or these receptors leads 
to the treatment of crescentic glomerulonephritis. 
In this study we investigated the difference of effect of TAK-603 caused by the period of 
administration.  It is remarkable that in rats administrated TAK-603 from day3, the 
amount of proteinuria decreased 40%.  Clinically, it is difficult to diagnose crescentic 
glomerulonephritis just as the disease break out.  It is rarely reported that 
anti-inflammatory drug was administrated after glomerulonephritis broke out(28).  Thus 
our finding seems to be valuable because it presents the possibility that suppression of 
Th1 cytokines may be clinically useful for crescentic glomerulonephritis.  Furthermore, 
crescentic formation was reduced in rats administrated TAK-603 only one day when 
nephritis was occuered.  This result suggests the importance of immediate treatment of 
glomerulonephritis, and Th1 dominant state is closely related with formation of early 
phase of glemerulonephritis, especially crescentic formation. 
In our study, administration of TAK-603 avoid exacerbation of glomerulonephritis to 
renal failure and pathologically supressed glemerulosclerosis.  It is worth noticing  this 
result suggests that Th1 suppression in the early phase of glomerulonephritis protects 
renal function in the long run.  One of the mechanisms of this drug is thought to suppress 
crescent formation itself.  There were also reported in this rat glomerulonephritis model 
crescent formation correlated with renal function(3,29).  Furthermore, in human 
glomerulonephritis, crescent formation itself regulates prognosis of renal function(30).  
Moreover, it seems important that administration of TAK-603 effects on reduction of 
proteinuria.  Recently relation between renal failure and continuous proteinuria itself or 
ingredients in it such as albumin, iron, transferring, lipoprotein, complement has been 
suggested.  That is, proteinuria which includes these ingredients causes glomerular or 
interstitial injury directly or through physiologic active substances such as endothelin-1, 
transforming growth factor(TGF)-β, activated oxygen and lysosome(31,32).  From the 
viewpoint of the fact that proteinuria itself commonly develops renal diseases, 
suppression of proteinuria by TAK-603 may protected renal function in the long term.   
Furthermore, in our study inhibitory effect of glomeruloscrelosis in the long run was 
suggested.  Suppression of Th1 in early phase seems to be important as regards to think 
of treatment of crescentic glomerulonephritis. 
In our study urinary IFN-γlevel was elevated in untreated rats, and the elevation was 
suppressed by administration of TAK-603.  This result gives the suggestion IFN-γ 
plays a key role of progression of crescent formation.  It is important that the wholly 
control of Th1 cytokines by TAK-603, which selectively inhibits Th1 Ｔ  cells is 
beneficial to treat crescentic glomerulonephritis. 
On the other side, in this study urinary IL-4 levels were not detected neither untreated 
groups nor treated groups.  TAK-603 suppressed the production of Th1 cytokines and 
not that of Th2 cytokines in adjuvant arthritis rats(5).  Glomerulosclerosis is mainly 
induced by accumulation of various extracellular matrix to mesangium lesion.  It is 
suggested that Th2 predominance promote glemeruloscrelosis and fibrosis(33,34).  Thus 
in our study, it was important whether early suppression of Th1 with TAK-603 cause Th2 
predominance, and consequently progress glomeruloscrelosis and fibrosis or not.  As a 
result, TAK-603 didn’t induce Th2 predominance from the viewpoint of urinary IL-4 
level on day 6. Thus it seems that this drug mainly control Th1 cytokines, and production 
of Th2 cytokines play little role. 
In summary, we reported that suppression of Th1 cytokines in early phase may improves 
crescentic glemerulonephritis and protects renal function in long term.   It seems 
important to work out strategy that contols Th1/Th2 cytokines in moderate phase of 
glomerulonephritis. 
